Cite
MLA Citation
Xu Pan et al.. “Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma.” Briefings in bioinformatics, vol. 23, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150514625.0x000044